Journal
NATURE IMMUNOLOGY
Volume 15, Issue 1, Pages 36-44Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2757
Keywords
-
Categories
Funding
- Marie-Curie Reintegration [256311]
- Israel Science Foundation [955/11, 1708/11]
- Israel Cancer Research Foundation Research Career Development Award
- Fritz Thyssen Foundation
- US-Israel Bi-national Science Foundation [2009222]
- US National Institutes of Health NIAID [R01AI083450, R37AI045898]
- Campaign Urging Research for Eisonophilic Disease (CURED) Foundation
- Buckeye Foundation
Ask authors/readers for more resources
Eosinophilia is a hallmark characteristic of T helper type 2 (T(H)2) cell-associated diseases and is critically regulated by the central eosinophil growth factor interleukin 5 (IL-5). Here we demonstrate that IL-5 activity in eosinophils was regulated by paired immunoglobulin-like receptors PIR-A and PIR-B. Upon self-recognition of beta(2)-microglobulin (beta M-2) molecules, PIR-B served as a permissive checkpoint for IL-5-induced development of eosinophils by suppressing the proapoptotic activities of PIR-A, which were mediated by the Grb2-Erk-Bim pathway. PIR-B-deficient bone marrow eosinophils underwent compartmentalized apoptosis, resulting in decreased blood eosinophilia in naive mice and in mice challenged with IL-5. Subsequently, Pirb(-/-) mice displayed impaired aeroallergen-induced lung eosinophilia and induction of lung T(H)2 cell responses. Collectively, these data uncover an intrinsic, self-limiting pathway regulating IL-5-induced expansion of eosinophils, which has broad implications for eosinophil-associated diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available